BioSpace News Archive

Viemed Healthcare, Inc., a national leader in respiratory care and technology-enabled home medical equipment services, reported its financial results for the three months and year ended December 31, 2022.

Biomerica, Inc., a global provider of advanced medical products, announced that it has commenced an underwritten public offering of its common stock.

Stryker announced the launch of its CD NXT System, the latest innovation in the company’s power tools.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”) announced today that it will be hosting a booth at the 30th Molecular and Precision Med TRI-CON (“TRI-CON”), held virtually and in person March 6-8, 2023, in San Diego, CA.

Prometheus Laboratories Inc. (“Prometheus”), a leader in precision healthcare, announced the launch of an induction-phase indication for PredictrPK IFX, a precision-guided dosing test.

Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), (“Braxia Scientific”, or the “Company”), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, today announced the successful identification of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both displaying versatile binding profiles and nanomolar affinity.

Convatec has received clearance from the U.S. Food and Drug Administration for its InnovaBurn® placental extracellular matrix medical device for management of complex surgical wounds and burns, including partial-thickness second-degree burns.

Harrow announced that it will release its financial results for the fourth quarter and year ended December 31, 2022, on Thursday, March 23, 2023, after the market close.

biote Corp. today announced its participation in the 35th Annual Roth Conference, to be held March 12-14, 2023, in Dana Point, CA.